A detailed history of Susquehanna Fundamental Investments, LLC transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Susquehanna Fundamental Investments, LLC holds 77,833 shares of TNDM stock, worth $2.79 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
77,833
Previous 37,705 106.43%
Holding current value
$2.79 Million
Previous $1.34 Billion 134.87%
% of portfolio
0.07%
Previous 0.06%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$30.43 - $53.43 $1.22 Million - $2.14 Million
40,128 Added 106.43%
77,833 $3.14 Billion
Q1 2024

May 07, 2024

BUY
$22.09 - $35.41 $832,903 - $1.34 Million
37,705 New
37,705 $1.34 Billion
Q3 2022

Nov 14, 2022

SELL
$43.76 - $68.97 $2.05 Million - $3.23 Million
-46,843 Reduced 58.72%
32,935 $1.58 Million
Q1 2022

May 16, 2022

BUY
$101.89 - $150.09 $2.29 Million - $3.37 Million
22,472 Added 39.21%
79,778 $9.28 Million
Q4 2021

Feb 14, 2022

BUY
$118.18 - $153.21 $381,130 - $494,102
3,225 Added 5.96%
57,306 $8.63 Million
Q3 2021

Nov 15, 2021

BUY
$93.51 - $129.4 $3.93 Million - $5.44 Million
42,038 Added 349.07%
54,081 $6.46 Million
Q2 2021

Aug 11, 2021

SELL
$77.0 - $100.19 $797,335 - $1.04 Million
-10,355 Reduced 46.23%
12,043 $1.17 Million
Q1 2021

May 17, 2021

SELL
$81.28 - $104.34 $605,698 - $777,541
-7,452 Reduced 24.96%
22,398 $1.98 Million
Q4 2020

Feb 16, 2021

SELL
$86.4 - $121.75 $364,867 - $514,150
-4,223 Reduced 12.39%
29,850 $2.86 Million
Q3 2020

Nov 16, 2020

BUY
$95.43 - $116.09 $207,369 - $252,263
2,173 Added 6.81%
34,073 $3.87 Million
Q2 2020

Aug 14, 2020

BUY
$60.05 - $98.92 $1.92 Million - $3.16 Million
31,900 New
31,900 $3.16 Million

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $2.31B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.